Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotectionJan Kubeš, Matthew J. Schellenberg, Olga Lenčová et al.|Nature Communications|2025Cited by 14
Topobexin Targets a Unique Druggable Pocket of Topoisomerase II for Beta Isoform- Selective Control of DNA Damage During Anthracycline ChemotherapyJan Kubeš, Matthew J. Schellenberg, Galina Karabanovich et al.|Structural Dynamics|2025Cited by 0